Burning Rock Biotech (BNR) Other Operating Expenses: 2020-2025
Historic Other Operating Expenses for Burning Rock Biotech (BNR) over the last 6 years, with Sep 2025 value amounting to -$5.9 million.
- Burning Rock Biotech's Other Operating Expenses rose 19.35% to -$5.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$27.4 million, marking a year-over-year increase of 81.91%. This contributed to the annual value of -$31.0 million for FY2024, which is 80.43% up from last year.
- Per Burning Rock Biotech's latest filing, its Other Operating Expenses stood at -$5.9 million for Q3 2025, which was down 9.33% from -$5.4 million recorded in Q2 2025.
- Burning Rock Biotech's 5-year Other Operating Expenses high stood at -$5.4 million for Q2 2025, and its period low was -$178.4 million during Q4 2022.
- In the last 3 years, Burning Rock Biotech's Other Operating Expenses had a median value of -$7.4 million in 2024 and averaged -$18.7 million.
- Per our database at Business Quant, Burning Rock Biotech's Other Operating Expenses plummeted by 71.44% in 2021 and then soared by 92.05% in 2024.
- Burning Rock Biotech's Other Operating Expenses (MRQ) stood at -$170.4 million in 2021, then decreased by 4.69% to -$178.4 million in 2022, then increased by 26.51% to -$131.1 million in 2023, then surged by 92.05% to -$10.4 million in 2024, then skyrocketed by 42.98% to -$5.9 million in 2025.
- Its last three reported values are -$5.9 million in Q3 2025, -$5.4 million for Q2 2025, and -$5.6 million during Q1 2025.